Health Discovery, DCL Ink Cancer Dx Collaboration | GenomeWeb

Health Discovery, DCL Ink Cancer Dx Collaboration

Jul 24, 2008

NEW YORK (GenomeWeb News) – Health Discovery Corporation has partnered with DCL Medical Laboratories to develop and commercialize DCL’s diagnostic tests for ovarian, cervical, and endometrial cancers.

Under the agreement, Savannah, Ga.-based HDC will own the developed intellectual property and DCL will have a sole-use license for applications and new mathematical tools that are developed over the course of the collaboration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

The Apple's Journey

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

This Week in Nature

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Change Is Hard to Do

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

Possible Paths for CUP

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.